Suppliers / Fuji Chemical Industries

Fuji Chemical Industries

Japan 29 employees Updated 9 July 2026

Fuji Chemical Industries is an API manufacturer based in Japan. It holds one active US drug master file across a filed portfolio of 3 molecules. Its GMP standing is certified by MFDS (Korea).

1
active US DMFs
0
valid CEPs
1
registered plants
0
filings across 0 regulators

Registered plants

Site FDA FEI
TOYAMA, Japan Not on file

What they file, and where

Molecule Regulators Docs
Favipiravir SFDA (Saudi Arabia) 1
Silodosin SFDA (Saudi Arabia) 1
Sucralfate US FDA 1

Also appears on these molecule pages

Favipiravir API Silodosin API Sucralfate API

Filings and GMP by regulator

Regulator Filings GMP certificates
MFDS (Korea) None 2

Questions about Fuji Chemical Industries

Does Fuji Chemical Industries hold a US DMF or a CEP?
Fuji Chemical Industries holds 1 active US drug master file. A drug master file is a submission to the FDA describing how an ingredient is made; a CEP is the EDQM's certificate that the substance meets its European Pharmacopoeia monograph. Both are filings rather than approvals.
Where does Fuji Chemical Industries manufacture?
1 registered site is on record, in Japan (Toyama). Every site is listed on this page with the register it came from.
What does Fuji Chemical Industries make?
3 molecules are on record against Fuji Chemical Industries, including Favipiravir, Silodosin and Sucralfate. Each links through to that molecule's full manufacturer list.
Which regulators recognise Fuji Chemical Industries's GMP?
Current GMP certificates are on record from MFDS (Korea). GMP recognition covers the manufacturing site, separately from any filing on the substance itself.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Fuji Chemical Industries comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Comparable suppliers

Zhejiang Huahai Pharmaceutical shares 2 molecules MSN Laboratories shares 1 molecule Apitoria Pharma shares 1 molecule Hetero shares 1 molecule Alivus Life Sciences shares 1 molecule

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
EudraGMDP and national regulators
GMP certificates